UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Karyopharm Therapeutics
KPTI
$48M
| $984K | ﹤0.01% |
3,464
-4
| -0.1% | -$1.18K |
|
1777
DNOW Inc
DNOW
$2.99B
| $983K | ﹤0.01% |
113,866
+3,148
| +3% | +$21.6K |
|
1778
Super Micro Computer
SMCI
$20.1B
| $981K | ﹤0.01% |
+345,660
| New | +$870K |
|
1779
Alector
ALEC
$199M
| $981K | ﹤0.01% |
+40,147
| New | +$1.11M |
|
|
VNE
1780
DELISTED
Veoneer, Inc.
VNE
| $981K | ﹤0.01% |
91,730
-38,466
| -30% | -$377K |
|
1781
iShares Russell 2000 Growth ETF
IWO
$15.1B
| $979K | ﹤0.01% |
4,732
-7,196
| -60% | -$1.35M |
|
|
LTHM
1782
DELISTED
Livent Corporation
LTHM
| $976K | ﹤0.01% |
158,514
-5,772
| -4% | -$36.4K |
|
1783
StoneCo
STNE
$2.58B
| $976K | ﹤0.01% |
+25,178
| New | +$734K |
|
1784
Madrigal Pharmaceuticals
MDGL
$11.8B
| $976K | ﹤0.01% |
8,615
+5,023
| +140% | +$494K |
|
|
SWI
1785
DELISTED
SolarWinds Corporation Common Stock
SWI
| $968K | ﹤0.01% |
+51,960
| New | +$958K |
|
1786
Malibu Boats
MBUU
$567M
| $967K | ﹤0.01% |
18,618
-1,845
| -9% | -$73.7K |
|
1787
CryoPort
CYRX
$762M
| $965K | ﹤0.01% |
31,906
+606
| +2% | +$13.5K |
|
1788
Enerpac Tool Group
EPAC
$1.93B
| $964K | ﹤0.01% |
54,785
-15,123
| -22% | -$255K |
|
|
NP
1789
DELISTED
Neenah, Inc. Common Stock
NP
| $962K | ﹤0.01% |
19,459
-3,095
| -14% | -$149K |
|
1790
First Commonwealth Financial
FCF
$2.17B
| $958K | ﹤0.01% |
115,721
-412
| -0.4% | -$3.48K |
|
1791
Axos Financial
AX
$5.68B
| $957K | ﹤0.01% |
43,358
-10,427
| -19% | -$212K |
|
|
BRMK
1792
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $957K | ﹤0.01% |
+101,027
| New | +$853K |
|
|
TSE
1793
DELISTED
Trinseo
TSE
| $950K | ﹤0.01% |
42,867
-4,756
| -10% | -$97.3K |
|
1794
Atara Biotherapeutics
ATRA
$76.1M
| $950K | ﹤0.01% |
2,607
+240
| +10% | +$60.6K |
|
|
MODN
1795
DELISTED
MODEL N, INC.
MODN
| $948K | ﹤0.01% |
27,260
-635
| -2% | -$18.5K |
|
1796
Southside Bancshares
SBSI
$967M
| $945K | ﹤0.01% |
34,093
+8,632
| +34% | +$245K |
|
|
VBTX
1797
DELISTED
Veritex Holdings
VBTX
| $939K | ﹤0.01% |
53,078
+5,953
| +13% | +$96.6K |
|
1798
Angi Inc
ANGI
$196M
| $934K | ﹤0.01% |
7,689
-2,179
| -22% | -$199K |
|
1799
3D Systems Corp
DDD
$613M
| $931K | ﹤0.01% |
133,245
+12,760
| +11% | +$95.4K |
|
1800
Camping World
CWH
$653M
| $928K | ﹤0.01% |
34,173
-3,032
| -8% | -$48.9K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.